EE167 Use of Cost per Responder Models for CAR-T Therapies in Relapsed or Refractory Multiple Myeloma
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.416
https://www.valueinhealthjournal.com/article/S1098-3015(22)00617-9/fulltext
Title :
EE167 Use of Cost per Responder Models for CAR-T Therapies in Relapsed or Refractory Multiple Myeloma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00617-9&doi=10.1016/j.jval.2022.04.416
First page :
Section Title :
Open access? :
No
Section Order :
10365